Previous 10 | Next 10 |
Capricor Therapeutics (NASDAQ: CAPR ) +26% on providing its CAP-1002 cell therapy under compassionate use for patients with advanced COVID-19. More news on: Capricor Therapeutics, Inc., Fate Therapeutics, Inc., SAExploration Holdings, Inc., Stocks on the move, Read m...
Gainers: Cellect Biotechnology (NASDAQ: APOP ) +109% . More news on: Cellect Biotechnology Ltd., ION Geophysical Corporation, Diamond Offshore Drilling, Inc., Stocks on the move, , Read more ...
Recently, Athersys has positioned MultiStem as a potential treatment for COVID-19-induced ARDS and highlighted the “highly relevant” BARDA designation that MultiStem received for COVID-19 and other pathogens. This has sent Athersys’ share price soaring up over 200% sin...
3 Penny Stocks To Watch This Week Penny stocks and blue-chips are both experiencing big bouts of volatility this week. This was partially due to the uncertainty surrounding the coronavirus. But we’ve also got to take into consideration the current state of the economy. Not only are ...
April 1, 2020 Palm Beach, FL – April 1, 2020 – The World House has called on U.S. health regulators to expedite potential therapies aimed at treating COVID-19 amid the fast-spreading coronavirus outbreak, saying it could lead to a breakthrough while a vaccine is still un...
4 Penny Stocks To Watch Right Now The markets are trading with a bit of chop today. There hasn’t been a defined directional move even amid upbeat economic data from China. But that hasn’t stopped penny stocks from producing big gains so far. In our morning update, several of th...
Amarin (NASDAQ: AMRN ) -68% after court decision on Vascepa. More news on: Amarin Corporation plc, Delphi Technologies PLC, SuperCom Ltd., Stocks on the move, , Read more ...
This is an important follow-up to my March 18, 2020, COVID-19 related article on Athersys Inc. ( ATHX ) that discussed the company's ongoing discussions with the Biomedical Advanced Research and Development Authority (BARDA) to bring an experimental treatment to COVID-19 patients suffering...
Are These Penny Stocks On The Top Of Your List Today? This week begins another volatile period of trading. While the broader markets gapped down on Monday morning, the opening bell saw a massive push to the upside. Right now we’re dealing with several key catalysts that are working in b...
Plus Therapeutics. (NASDAQ: PSTV ) +63% in-licenses novel oncology candidates. More news on: Plus Therapeutics, Inc., Bellerophon Therapeutics, Inc., Owens & Minor, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem ® (invimestrocel) for critical care indications, announces it has entered into a warrant exercise inducement offer letter to ra...